NCT05540418

Brief Summary

Aim: In this study, it was aimed to determine the effect of lavender oil inhalation on the anxiety and comfort levels of patients who will undergo colonoscopy. Material and Method: In this randomized controlled, prospective study, 73 experimental and 72 control group patients who will experience colonoscopy in a training and research hospital in western Turkey were included. While lavender inhalation was applied to the patients in the experimental group, routine care was applied to the patients in the control group. The short-form state-trait anxiety scale and general comfort scale were used to collect data before and after the procedure. p\<0.05 level was considered statistically significant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
145

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2022

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 3, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 4, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 14, 2022

Completed
Last Updated

October 10, 2023

Status Verified

September 1, 2022

Enrollment Period

2 months

First QC Date

September 4, 2022

Last Update Submit

October 6, 2023

Conditions

Keywords

colonoscopyaromatherapyanxietycomfortlavander oil

Outcome Measures

Primary Outcomes (2)

  • Change of the State-Trait Anxiety Inventory scores

    State anxiety inventory determines how an individual feels at a certain moment and under certain conditions. The trait anxiety inventory, on the other hand, is defined as the anxiety that an individual feels in his normal life. Each item in the inventory is evaluated between one and four points. High total scores in the inventories indicate a high state anxiety level of the individual. In the inventory, scores above 42 are considered as "high anxiety level". The internal consistency (Cronbach's Alpha) coefficients of this inventory range from 0.83 to 0.92 for the state anxiety inventory. The State-Trait Anxiety inventory was evaluated 20 minutes before and 20 minutes after colonoscopy in the intervention and control groups. Anxiety level was evaluated with the State-Trait Anxiety inventory before and 20 minutes after lavender oil inhalation in patients in the intervention group.

    Before the colonoscopic procedure - on colonoscopic procedure day

  • Change of the Overal Comfort Scale

    General Comfort Scale: The scale consists of 28 questions and shows the current comfort status of the patient. The score of the scale varies between 28-168. The Cronbach alpha of the 6-point Likert-type scale is 0.82. The general comfort scale was evaluated 20 minutes before and 20 minutes after colonoscopy in the intervention and control groups. Overall comfort level was assessed before and 20 minutes after lavender oil inhalation in patients in the intervention group. A high score on the scale indicates that the general comfort level of the patients is high.

    Before the colonoscopic procedure - on colonoscopic procedure day

Study Arms (2)

Experimental group

EXPERIMENTAL

Pre-procedural information form, state-trait anxiety scale, and comfort scale were applied to patients who had planned colonoscopy. Two drops of lavender (2%) essential oil was dripped onto a 2 x 2 cm cotton gauze cloth attached to the front of the clothes of the experimental group patients, approximately 12 inches below their noses. They were asked to inhale 2% lavender essential oil for 20 minutes. They were directed to breathe normally after inhalation. Vital signs of the patients were checked before and after the procedure. After the process, the forms were filled again, the final test process was completed.

Other: lavender oil inhalation

Control Group

NO INTERVENTION

Pre-procedural information form, state-trait anxiety scale, and comfort scale were applied to patients who had planned colonoscopy. Lavender aromatherapy was not applied to the patients in this group, but routine care was applied. After the process, the forms were filled again, the final test process was completed. The data took about 15-20 minutes with face-to-face interview method.

Interventions

Two drops of lavender (2%) essential oil were dripped onto a 2 x 2 cm cotton gauze cloth attached to the front of the clothes of the experimental group patients, approximately 12 inches below their noses. They were asked to inhale 2% lavender essential oil for 20 minutes. They were directed to breathe normally after inhalation. Vital signs of the patients were checked before and after the procedure. After the process, the forms were filled again, the final test process was completed.

Experimental group

Eligibility Criteria

Age44 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • over 18 years old, 65 years old and under,
  • having colonoscopy,
  • not having the risk of heart failure and cardiogenic shock (class III and IV),
  • not having a history of asthma, eczema, and allergies to flowers and plants,
  • not allergic to lavender,
  • not having communicative/severe hearing or speech impairment,
  • not using antidepressant, antihistamine, diuretic, hypnotic, benzodiazepine and narcotic derivatives
  • having stable vital signs
  • individuals who volunteered to participate in research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırklareli University

Kırklareli, Faculty of Health Sciences, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Colonic DiseasesAnxiety Disorders

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMental Disorders

Study Officials

  • Aylin AYDIN SAYILAN, Assoc.Prof.

    Kırklareli Universitiy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized controlled experimental study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist. Prof. Dr.

Study Record Dates

First Submitted

September 4, 2022

First Posted

September 14, 2022

Study Start

June 15, 2022

Primary Completion

August 15, 2022

Study Completion

September 3, 2022

Last Updated

October 10, 2023

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations